← Leaderboards
Christopher E Barbieri
Weill Medical Coll Of Cornell Univ
$8,793,376
Attributed
$10,685,221
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,685,221 · 7
By mechanism
R01$5,428,894 · 4
R37$2,630,925 · 1
P50$1,760,862 · 1
K08$864,540 · 1
Top collaborators
- Noah Dephoure3 shared
- Pengbo Zhou2 shared
- David S. Rickman1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Pengbo Zhou$14,509,570
- Howard A. Fine$6,388,702
- Augustine M Choi$36,719,348
- Fernando J Martinez$34,787,404
- Kymora B Scotland$678,785
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSamplingProstateMalignant Neoplasm Of ProstateMutationMutantRecurrenceMolecularIn VitroAffectCohortGenetically Engineered MouseDna Sequence AlterationPathogenesisClinical TrialsGenesOncogenicProstate CarcinogenesisFoundationsIn VivoMouse ModelEventCellsBase
Grant awards (26)
Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer$710,980
R01 · FY2025 · CA
The role of early oncogenic drivers in maintaining lineage fidelity in prostate cancer$683,979
R01 · FY2025 · CA · contact PI
Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancer$564,543
R01 · FY2025 · CA · contact PI
Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer$710,980
R01 · FY2024 · CA
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$342,927
R37 · FY2024 · CA · contact PI
Collaborative genomic alterations and transcriptional control in prostate cancer$538,985
R01 · FY2023 · CA · contact PI
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$360,976
R37 · FY2023 · CA · contact PI
Collaborative genomic alterations and transcriptional control in prostate cancer$541,675
R01 · FY2022 · CA · contact PI
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$387,731
R37 · FY2022 · CA · contact PI
Collaborative genomic alterations and transcriptional control in prostate cancer$560,025
R01 · FY2021 · CA · contact PI
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$387,731
R37 · FY2021 · CA · contact PI
Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer$343,883
P50 · FY2021 · CA · contact PI
Collaborative genomic alterations and transcriptional control in prostate cancer$559,319
R01 · FY2020 · CA · contact PI
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$387,731
R37 · FY2020 · CA · contact PI
Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer$351,279
P50 · FY2020 · CA · contact PI
Collaborative genomic alterations and transcriptional control in prostate cancer$558,408
R01 · FY2019 · CA · contact PI
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$376,098
R37 · FY2019 · CA · contact PI
Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer$343,883
P50 · FY2019 · CA · contact PI
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer$387,731
R37 · FY2018 · CA · contact PI
Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer$370,291
P50 · FY2018 · CA · contact PI
Genomic instability and DNA repair in a distinct molecular class of prostate canc$172,908
K08 · FY2018 · CA · contact PI
Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer$351,526
P50 · FY2017 · CA · contact PI
Genomic instability and DNA repair in a distinct molecular class of prostate canc$172,908
K08 · FY2017 · CA · contact PI
Genomic instability and DNA repair in a distinct molecular class of prostate canc$172,908
K08 · FY2016 · CA · contact PI
Genomic instability and DNA repair in a distinct molecular class of prostate canc$172,908
K08 · FY2015 · CA · contact PI
Genomic instability and DNA repair in a distinct molecular class of prostate canc$172,908
K08 · FY2014 · CA · contact PI